Cencora, Inc. (BVMF:C1CO34)

Market Cap	364.17B +24.5%
Revenue (ttm)	1.79T +7.4%
Net Income	8.95B +16.4%
EPS	45.88 +18.6%
Shares Out	n/a
PE Ratio	40.68
Forward PE	20.02
Dividend	4.23 (0.46%)
Ex-Dividend Date	Nov 13, 2025

Volume	3
Average Volume	39
Open	923.80
Previous Close	923.87
Day's Range	923.80 - 923.80
52-Week Range	729.90 - 960.00
Beta	0.69
RSI	55.99
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: C1CO34

Financial Performance

In fiscal year 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD